MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice
Our results demonstrated that MUC17 has a central role in bile-induced PC progression, and in addition to MUC4, this isoform also can be used as a novel prognostic biomarker.
Authors
- Zoltán Veréb (ORCID: https://orcid.org/0000-0002-9518-2155)
- Zoltán Márton Köhler (ORCID: https://orcid.org/0000-0002-8299-105X)
- László Czakó (ORCID: https://orcid.org/0000-0002-6331-0802)
- Viktória Venglovecz (ORCID: https://orcid.org/0000-0002-2316-7247)
- Dávid Rakk
- Eleonóra Gál
- András Szekeres (ORCID: https://orcid.org/0000-0003-1651-4623)
- Tamás Takács (ORCID: https://orcid.org/0000-0003-3321-8690)
- László Tiszlavicz (ORCID: https://orcid.org/0000-0003-1134-6587)
- Anikó Keller-Pintér (ORCID: https://orcid.org/0000-0002-4105-8458)
- István Menyhárt
- Lajos Vince Kemény (ORCID: https://orcid.org/0000-0002-2119-9501)
- Boshra Yosef
- Péter Hegyi
Institutions
- Semmelweis University (HU)
- University of Szeged (HU)
- University of Pecs (HU)
Publication Details
- Journal
- Oncology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1159/000541874
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- European Commission
- European Regional Development Fund